Cargando…

DNA hypermethylation markers of poor outcome in laryngeal cancer

This study examined molecular (DNA hypermethylation), clinical, histopathological, demographical, smoking, and alcohol variables to assess diagnosis (early versus late stage) and prognosis (survival) outcomes in a retrospective primary laryngeal squamous cell carcinoma (LSCC) cohort. The study cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephen, Josena K., Chen, Kang Mei, Shah, Veena, Havard, Shaleta, Kapke, Alissa, Lu, Mei, Benninger, Michael S., Worsham, Maria J.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037188/ https://www.ncbi.nlm.nih.gov/pubmed/21318053 http://dx.doi.org/10.1007/s13148-010-0005-3

Ejemplares similares

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Methylation Markers for Early Detection and Differentiation of Follicular Thyroid Cancer Subtypes
por: Stephen, Josena K., et al.
Publicado: (2015)

DNA Methylation in Thyroid Tumorigenesis
por: Stephen, Josena K., et al.
Publicado: (2011)

Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer
por: Chen, Kang Mei, et al.
Publicado: (2011)

The biological significance of methylome differences in human papilloma virus associated head and neck cancer
por: Worsham, Maria J., et al.
Publicado: (2016)

Allergic laryngitis: chronic laryngitis and allergic sensitization()
por: Campagnolo, Andrea, et al.
Publicado: (2019)

Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma
por: Huang, Chuang, et al.
Publicado: (2016)

DNA Hypermethylation and Inflammatory Markers in Incident Japanese Dialysis Patients
por: Kato, Sawako, et al.
Publicado: (2012)

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
por: Fu, Siyu, et al.
Publicado: (2023)

AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis
por: Hao, Xuewei, et al.
Publicado: (2022)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome
por: Bai, Yu, et al.
Publicado: (2014)

SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males
por: Shen, Zhisen, et al.
Publicado: (2016)

Discovery and Validation of Hypermethylated Markers for Colorectal Cancer
por: Wei, Jiufeng, et al.
Publicado: (2016)

Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2016)

Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
por: van Zogchel, Lieke M. J., et al.
Publicado: (2020)

Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma
por: Yang, Min, et al.
Publicado: (2012)

LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2018)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

Poor outcome of comprehensive therapy in a case of laryngeal synovial sarcoma
por: Bao, Yang-Yang, et al.
Publicado: (2013)

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
por: Guo, Hong, et al.
Publicado: (2017)

Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients
por: Søgaard Helbo, Alexandra, et al.
Publicado: (2015)

Hypermethylation of ribosomal DNA in human breast carcinoma
por: Yan, P S, et al.
Publicado: (2000)

Hiwi Mediated Tumorigenesis Is Associated with DNA Hypermethylation
por: Siddiqi, Sara, et al.
Publicado: (2012)

Global DNA Hypermethylation in Down Syndrome Placenta
por: Jin, Shengnan, et al.
Publicado: (2013)

DNA hypermethylation in disease: mechanisms and clinical relevance
por: Ehrlich, Melanie
Publicado: (2019)

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2017)

DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour
por: Mi, Tao, et al.
Publicado: (2022)

Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020
por: Young, Eric W., et al.
Publicado: (2022)

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
por: PETERS, INGA, et al.
Publicado: (2014)

Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
por: Nomoto, S, et al.
Publicado: (2007)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Changsong, et al.
Publicado: (2012)

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma
por: Wu, Meei-Maan, et al.
Publicado: (2017)

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
por: Zhang, Hui, et al.
Publicado: (2021)

The role of dna hypermethylation and demethylation in cancer and cancer therapy
por: Szyf, M.
Publicado: (2008)

DNA Hypermethylation of Tumor-Related Genes in Gastric Carcinoma
por: Hong, Su Hyung, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_0t52pvubtb51pnta58t7khrmgv